Clinical trials
Phase 1 Neoplasm Metastasis trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
67 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 2 |
| 2009 | 2 |
| 2010 | 4 |
| 2011 | 1 |
| 2013 | 1 |
| 2015 | 3 |
| 2016 | 4 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 7 |
| 2021 | 6 |
| 2022 | 7 |
| 2023 | 6 |
| 2024 | 9 |
| 2025 | 6 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 22 |
| Recruiting | 18 |
| Terminated | 15 |
| Active, not recruiting | 8 |
| Unknown status | 3 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 6 |
| OncoMed Pharmaceuticals, Inc. | 3 |
| AbbVie | 2 |
| Amgen | 2 |
| BeOne Medicines | 2 |
| EMD Serono Research & Development Institute, Inc. | 2 |
| Genentech, Inc. | 2 |
| Novartis Pharmaceuticals | 2 |
| TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics) | 2 |
| Turning Point Therapeutics, Inc. | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neoplasm Metastasis | 67 |
| Colorectal Neoplasms | 21 |
| Carcinoma, Non-Small-Cell Lung | 19 |
| Neoplasms | 19 |
| Pancreatic Neoplasms | 12 |
| Breast Neoplasms | 11 |
| Melanoma | 10 |
| Ovarian Neoplasms | 10 |
| Triple Negative Breast Neoplasms | 10 |
| Uterine Cervical Neoplasms | 9 |
Trials
Showing 1 to 25 of 67. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.